By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EPIRUS Biopharmaceuticals 

699 Boylston Street
11th Floor
Boston  Massachusetts   02116  U.S.A.
Phone: n/a Fax: n/a


Company News
EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Provides Business Update 11/16/2015 8:28:14 AM
EPIRUS Biopharmaceuticals Provides Clinical Program Update On BOW015 (Infliximab Biosimilar) 11/16/2015 7:50:55 AM
EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Results Conference Call And Webcast 11/12/2015 7:21:36 AM
EPIRUS Biopharmaceuticals Appoints Industry Veteran Vincent E. Aurentz As Chief Business Officer 11/10/2015 8:23:52 AM
EPIRUS Biopharmaceuticals Joins Biosimilars Forum To Help Educate Patients And Healthcare Providers On Importance Of Biosimilars 11/5/2015 10:32:16 AM
EPIRUS Biopharmaceuticals To Release Third Quarter 2015 Financial Results And Provide Business Update 10/29/2015 9:27:12 AM
EPIRUS Biopharmaceuticals Expands Biosimilar Pipeline And Capabilities Through Acquisition Of Bioceros 9/9/2015 7:54:42 AM
EPIRUS Biopharmaceuticals And Polpharma SA Enter Into A Multi-Product, Multi-Region, Profit-Sharing Collaboration To Advance Biosimilar Portfolio Targeting $6 Billion Addressable Innovator Market 7/14/2015 7:20:10 AM
EPIRUS Biopharmaceuticals Presents New BOW015 (Infliximab Biosimilar) Data At The European League Against Rheumatism Annual Congress (EULAR 2015) 6/10/2015 8:18:21 AM
EPIRUS Biopharmaceuticals Reports First Quarter 2015 Financial Results 5/12/2015 10:37:36 AM